This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Samyang Biopharmaceuticals Corporation. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Hye Won Kang - Innovator in Anticancer Formulations
Introduction
Hye Won Kang is a notable inventor based in Namyangju-si, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative drug formulations.
Latest Patents
Hye Won Kang holds a patent for a "Polymer nanoparticle injection formulation composition containing rapamycin with improved water solubility." This invention focuses on enhancing the water solubility of rapamycin, a compound known for its anticancer properties. The formulation utilizes polymer nanoparticles to solubilize rapamycin, making it more effective for therapeutic applications, especially in combination with radiotherapy.
Career Highlights
Kang is associated with Samyang Biopharmaceuticals Corporation, where he continues to advance research in drug delivery systems. His work is pivotal in addressing challenges related to the solubility of therapeutic agents, which is crucial for their efficacy in clinical settings.
Collaborations
He collaborates with talented colleagues, including Min Hyo Seo and Sa Won Lee, who contribute to the innovative research environment at Samyang Biopharmaceuticals Corporation.
Conclusion
Hye Won Kang's contributions to the field of biopharmaceuticals, particularly through his patented formulation, highlight his role as an innovator in the fight against cancer. His work exemplifies the importance of developing effective drug delivery systems for improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile